AAAAAA
Results:
1-12
|
Results: 12
Authors:
Poyurovsky, M
Hramenkov, S
Isakov, V
Rauchverger, B
Modai, I
Schneidman, M
Fuchs, C
Weizman, A
Citation: M. Poyurovsky et al., Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia, PSYCHIAT R, 102(1), 2001, pp. 49-57
Authors:
Poyurovsky, M
Weizman, A
Citation: M. Poyurovsky et A. Weizman, Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: anew approach to an old problem, BR J PSYCHI, 179, 2001, pp. 4-8
Authors:
Poyurovsky, M
Weizman, A
Citation: M. Poyurovsky et A. Weizman, Mirtazapine for neuroleptic-induced akathisia, AM J PSYCHI, 158(5), 2001, pp. 819-819
Authors:
Poyurovsky, M
Nave, R
Epstein, R
Tzischinsky, O
Schneidman, M
Barnes, TRE
Weizman, A
Lavie, P
Citation: M. Poyurovsky et al., Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia, EUR NEUROPS, 10(3), 2000, pp. 171-176
Authors:
Frisch, A
Michaelovsky, E
Rockah, R
Amir, I
Hermesh, H
Laor, N
Fuchs, C
Zohar, J
Lerer, B
Buniak, SF
Landa, S
Poyurovsky, M
Shapira, B
Weizman, R
Citation: A. Frisch et al., Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways, EUR NEUROPS, 10(3), 2000, pp. 205-209
Authors:
Silver, H
Barash, I
Aharon, N
Kaplan, A
Poyurovsky, M
Citation: H. Silver et al., Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study, INT CLIN PS, 15(5), 2000, pp. 257-261
Authors:
Poyurovsky, M
Dorfman-Etrog, P
Hermesh, H
Munitz, H
Tollefson, GD
Weizman, A
Citation: M. Poyurovsky et al., Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms, INT CLIN PS, 15(3), 2000, pp. 169-173
Authors:
Frisch, A
Postilnick, D
Rockah, R
Michaelovsky, E
Postilnick, S
Birman, E
Laor, N
Rauchverger, B
Kreinin, A
Poyurovsky, M
Schneidman, M
Modai, I
Weizman, R
Citation: A. Frisch et al., Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways, MOL PSYCHI, 4(4), 1999, pp. 389-392
Authors:
Poyurovsky, M
Weizman, A
Citation: M. Poyurovsky et A. Weizman, Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia, INT CLIN PS, 14(6), 1999, pp. 357-360
Authors:
Poyurovsky, M
Isakov, V
Hromnikov, S
Modai, I
Rauchberger, B
Schneidman, M
Weizman, A
Citation: M. Poyurovsky et al., Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study, INT CLIN PS, 14(2), 1999, pp. 95-100
Authors:
Poyurovsky, M
Shardorodsky, M
Fuchs, C
Schneidman, M
Weizman, A
Citation: M. Poyurovsky et al., Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin - Double-blind, placebo-controlled study, BR J PSYCHI, 174, 1999, pp. 238-242
Authors:
Poyurovsky, M
Fuchs, C
Weizman, A
Citation: M. Poyurovsky et al., Obsessive-compulsive disorder in patients with first-episode schizophrenia, AM J PSYCHI, 156(12), 1999, pp. 1998-2000
Risultati:
1-12
|